RNAZ | TransCode Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.2559 - 0.2690
52 Week Range	0.2160 - 128.00
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	437,212
Average Volume	1,186,683
Shares Outstanding	17,265,700
Market Cap	4,495,988
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-07-08

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	268.14
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	10
Country	USA
Website	RNAZ

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. Its cancer agnostic programs comprise TTX-RIGA, an RNA–based agonist of the RIG-I-driven immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9–based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines meant to activate cytotoxic immune responses against tumor cells. The company was incorporated in 2016 and is based in Boston, Massachusetts.

RNAZ's peers: ADIL, AEZS, ATNM, AVXL, CANF, CGTX, CRDF, DRUG, EVAX, EYEN, EZFL, FBIO, GNPX, KOD, LEXX, LPCN, MEIP, NERV, OCUP, REVB, LABP, NEXI, ONCR, XBIO, RVPHW, IMMX, CNSP, EFTR, NAVB, SONN, ZURA, PHIO, ZVSA, SLS, TCBP, UNCY, VIRI, VYNE, ERNA, ZVRA

*Chart delayed

Analyzing fundamentals for RNAZ we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see RNAZ Fundamentals page.

Watching at RNAZ technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on RNAZ Technicals page.